BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18537576)

  • 1. An update on clinical drug interactions with the herbal antidepressant St. John's wort.
    Zhou SF; Lai X
    Curr Drug Metab; 2008 Jun; 9(5):394-409. PubMed ID: 18537576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical drugs that interact with St. John's wort and implication in drug development.
    Di YM; Li CG; Xue CC; Zhou SF
    Curr Pharm Des; 2008; 14(17):1723-42. PubMed ID: 18673195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
    Galeotti N
    J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.
    Borrelli F; Izzo AA
    AAPS J; 2009 Dec; 11(4):710-27. PubMed ID: 19859815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical risks of St John's Wort (Hypericum perforatum) co-administration.
    Soleymani S; Bahramsoltani R; Rahimi R; Abdollahi M
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1047-1062. PubMed ID: 28885074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.
    Henderson L; Yue QY; Bergquist C; Gerden B; Arlett P
    Br J Clin Pharmacol; 2002 Oct; 54(4):349-56. PubMed ID: 12392581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.
    Izzo AA
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):139-48. PubMed ID: 15049433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.
    Berry-Bibee EN; Kim MJ; Tepper NK; Riley HE; Curtis KM
    Contraception; 2016 Dec; 94(6):668-677. PubMed ID: 27444983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of the herbal antidepressant St. John's wort (Hypericum perforatum) on rat gastric motility.
    Capasso R; Borrelli F; Aviello G; Capasso F; Izzo AA
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):407-14. PubMed ID: 18172613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for interaction of kava and St. John's wort with drugs.
    Singh YN
    J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages and Disadvantages of Using St. John's Wort as a Treatment for Depression.
    Canenguez Benitez JS; Hernandez TE; Sundararajan R; Sarwar S; Arriaga AJ; Khan AT; Matayoshi A; Quintanilla HA; Kochhar H; Alam M; Mago A; Hans A; Benitez GA
    Cureus; 2022 Sep; 14(9):e29468. PubMed ID: 36299970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phytotherapy threats with emphasis on St. John's wort medicines].
    Sienkiewicz J; Czarnik-Matusewicz H; Wiela-HojeĊ„ska A
    Pol Merkur Lekarski; 2013 Nov; 35(209):309-12. PubMed ID: 24575655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR- and CYP3A4-mediated drug-herbal interactions.
    Pal D; Mitra AK
    Life Sci; 2006 Mar; 78(18):2131-45. PubMed ID: 16442130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St John's wort for depression: scoping review about perceptions and use by general practitioners in clinical practice.
    Forsdike K; Pirotta M
    J Pharm Pharmacol; 2019 Jan; 71(1):117-128. PubMed ID: 28653745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.